Trials / Unknown
UnknownNCT02297542
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 85 (estimated)
- Sponsor
- Health Sciences North Research Institute · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
This 5-year proposal is a randomized study of split-virus influenza vaccine (SVV) in a high-dose (HD) vs. standard-dose (SD) formulation in each of five influenza seasons to define the key determinants of vaccine-mediated protection against influenza and how these immunologic mediators may be enhanced by vaccination with a newly approved high-dose influenza vaccine in older people
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Flu Vaccine |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2014-11-21
- Last updated
- 2018-08-01
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02297542. Inclusion in this directory is not an endorsement.